IMU 0.00% 5.1¢ imugene limited

Media Thread, page-11715

  1. 515 Posts.
    lightbulb Created with Sketch. 272

    Well are in the frame so to speak

    Merck keeps deal focus with Keytruda patent cliff on horizon

    The company is open to acquisitions of up to $15 billion, company CEO Rob Davis said Thursday on a fourth quarter earnings call.


    Full Article

    https://www.biopharmadive.com/news/merck-dealmaking-15-billion-keytruda-cliff-davis/706309/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue:%202024-02-07%20BioPharma%20Dive:%20Commercialization%20%5Bissue:58939%5D&utm_term=BioPharma%20Dive:%20Commercialization
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.1¢
Change
0.000(0.00%)
Mkt cap ! $373.3M
Open High Low Value Volume
5.1¢ 5.2¢ 4.9¢ $1.384M 27.31M

Buyers (Bids)

No. Vol. Price($)
7 1302118 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
5.2¢ 528865 4
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.